Prevalence and prognostic relevance of tricuspid regurgitation in different heart failure entities

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023081

Enrollment

1000

Registered

2020-10-05

Start date

2020-06-26

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tricuspid regurgitationheart failure I36.1 I50

Interventions

Group 1: After enrolement, we perform telephone visits after 3, 6, 12 and 24 months (symptoms, letality).

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: heart failure, tricuspid regurgitation, > 18 years, written informed consent

Exclusion criteria

Exclusion criteria: patients who are unable to consent

Design outcomes

Primary

Measure	Time frame
Overall mortality after 3 months	—

Secondary

Measure	Time frame
hospitalization due to cardiac decompensation, exercise capacity according to NYHA classification after 3 months	—

Countries

Germany

Contacts

Public ContactHenryk Dreger

Medizinische Klinik m. S. Kardiologie und AngiologieCharité Campus MitteCharité - Universitätsmedizin Berlin

henryk.dreger@charite.de+4030450613496

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026